331 related articles for article (PubMed ID: 18223326)
1. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions.
Mao TL; Kurman RJ; Jeng YM; Huang W; Shih IeM
Am J Surg Pathol; 2008 Feb; 32(2):236-42. PubMed ID: 18223326
[TBL] [Abstract][Full Text] [Related]
2. HSD3B1 is a specific trophoblast-associated marker not expressed in a wide spectrum of tumors.
Chou YY; Jeng YM; Mao TL
Int J Gynecol Cancer; 2013 Feb; 23(2):343-7. PubMed ID: 23318910
[TBL] [Abstract][Full Text] [Related]
3. Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions.
Shih IeM
Ann Diagn Pathol; 2007 Jun; 11(3):228-34. PubMed ID: 17498600
[TBL] [Abstract][Full Text] [Related]
4. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM
Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor--an aid in differential diagnosis.
Mao TL; Seidman JD; Kurman RJ; Shih IeM
Am J Surg Pathol; 2006 Sep; 30(9):1105-10. PubMed ID: 16931955
[TBL] [Abstract][Full Text] [Related]
7. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
Shih IM; Kurman RJ
Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical studies of trophoblastic tumors.
Kalhor N; Ramirez PT; Deavers MT; Malpica A; Silva EG
Am J Surg Pathol; 2009 Apr; 33(4):633-8. PubMed ID: 19145204
[TBL] [Abstract][Full Text] [Related]
10. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
Shih IM; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
[TBL] [Abstract][Full Text] [Related]
11. Proliferations and tumors of intermediate trophoblast of the placental site.
Young RH; Kurman RJ; Scully RE
Semin Diagn Pathol; 1988 May; 5(2):223-37. PubMed ID: 2840724
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
[TBL] [Abstract][Full Text] [Related]
13. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
14. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions.
Xue WC; Khoo US; Ngan HY; Chan KY; Ip PP; Tsao SW; Cheung AN
Int J Gynecol Pathol; 2004 Apr; 23(2):145-50. PubMed ID: 15084843
[TBL] [Abstract][Full Text] [Related]
15. Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease.
Bozić M; Petronijević M; Milenković S; Atanacković J; Lazić J; Vićovac Lj
Placenta; 2004 Nov; 25(10):797-802. PubMed ID: 15451194
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of Ras GTPase activating protein in human trophoblastic tumors.
Ståhle-Bäckdhal M; Inoue M; Zedenius J; Sandstedt B; DeMarco L; Flam F; Silfverswärd C; Andrade J; Friedman E
Am J Pathol; 1995 May; 146(5):1073-8. PubMed ID: 7747802
[TBL] [Abstract][Full Text] [Related]
17. GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility.
Banet N; Gown AM; Shih IeM; Kay Li Q; Roden RB; Nucci MR; Cheng L; Przybycin CG; Nasseri-Nik N; Wu LS; Netto GJ; Ronnett BM; Vang R
Am J Surg Pathol; 2015 Jan; 39(1):101-8. PubMed ID: 25188865
[TBL] [Abstract][Full Text] [Related]
18. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis.
Singer G; Kurman RJ; McMaster MT; Shih IeM
Am J Surg Pathol; 2002 Jul; 26(7):914-20. PubMed ID: 12131159
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of the cell cycle promoter cyclin e in benign extravillous trophoblast and gestational trophoblastic lesions: correlation with expression of Ki-67.
Bamberger AM; Aupers S; Milde-Langosch K; Löning T
Int J Gynecol Pathol; 2003 Apr; 22(2):156-61. PubMed ID: 12649670
[TBL] [Abstract][Full Text] [Related]
20. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]